a clinical stage biopharmaceutical company
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DLDRX | 49.62 | -0.11 | -0.22% |
BNY Mellon Natural Resources I | |||
DURIX | 12.97 | -0.08 | -0.61% |
DWS ESG International Core Eq Instl | |||
FSCPX | 67.89 | -0.79 | -1.15% |
Fidelity Select Consumer Discret Port | |||
GMCQX | 14.47 | -0.21 | -1.43% |
GMO US Equity VI | |||
JAGLX | 73.70 | -2.12 | -2.80% |
Janus Henderson Global Life Sciences T |
A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.
Ticker / NAME | Correlation To FATE | 1D Price Change % | ||
---|---|---|---|---|
FATE | 100% | -2.88% | ||
ALLO - FATE | 55% Loosely correlated | -7.72% | ||
ABCL - FATE | 54% Loosely correlated | -3.99% | ||
INZY - FATE | 53% Loosely correlated | -8.89% | ||
NTLA - FATE | 53% Loosely correlated | -7.61% | ||
BEAM - FATE | 52% Loosely correlated | -8.59% | ||
More |